Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALFRED G AJISE

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1164742268
CMS profile
624185
Location
NATCHITOCHES, LA

General Payments · PY2018–2024

$1,720.63

  • Reported across 85 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$302.88

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $302.88 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Fresenius USA Marketing, Inc. $261.58 13
Acerta Pharma LLC $41.30 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $93.74 6
PY2019 $100.74 9
PY2020 $76.12 4
PY2021 $393.82 12
PY2022 $332.46 17
PY2023 $420.87 22
PY2024 $302.88 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $23.76 04/02/2024 Food and Beverage Undisputed 01/23/2026 1105602994 CMS
AstraZeneca Pharmaceuticals LP $17.54 10/07/2024 Food and Beverage Undisputed 01/23/2026 1104498480 CMS
Fresenius USA Marketing, Inc. $18.95 01/19/2024 Food and Beverage Undisputed 01/23/2026 1154204758 CMS
Fresenius USA Marketing, Inc. $21.10 02/27/2024 Food and Beverage Undisputed 01/23/2026 1154204764 CMS
Fresenius USA Marketing, Inc. $4.00 03/15/2024 Food and Beverage Undisputed 01/23/2026 1154204752 CMS
Fresenius USA Marketing, Inc. $19.11 03/15/2024 Food and Beverage Undisputed 01/23/2026 1154204760 CMS
Fresenius USA Marketing, Inc. $24.46 03/19/2024 Food and Beverage Undisputed 01/23/2026 1154204774 CMS
Fresenius USA Marketing, Inc. $20.06 04/09/2024 Food and Beverage Undisputed 01/23/2026 1154204762 CMS
Fresenius USA Marketing, Inc. $24.62 04/16/2024 Food and Beverage Undisputed 01/23/2026 1154204776 CMS
Fresenius USA Marketing, Inc. $24.11 04/19/2024 Food and Beverage Undisputed 01/23/2026 1154204770 CMS
Fresenius USA Marketing, Inc. $24.25 05/21/2024 Food and Beverage Undisputed 01/23/2026 1154204772 CMS
Fresenius USA Marketing, Inc. $17.77 07/16/2024 Food and Beverage Undisputed 01/23/2026 1154204754 CMS
Fresenius USA Marketing, Inc. $17.85 07/19/2024 Food and Beverage Undisputed 01/23/2026 1154204756 CMS
Fresenius USA Marketing, Inc. $21.58 08/20/2024 Food and Beverage Undisputed 01/23/2026 1154204766 CMS
Fresenius USA Marketing, Inc. $23.72 11/19/2024 Food and Beverage Undisputed 01/23/2026 1154204768 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.